-
-
-
-
-
-
-
QIAGEN Reports Full Results for Q1 2026
-
-
-
-
-
-
-
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
-
-
-
-
-
-
-
QIAGEN Unveils QIAsymphony Connect and Showcases New Precision Oncology Innovations at AMP 2025
-
-
-
-
-
-
-
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million
-
-
-
-
-
-
-
QIAGEN Celebrates Surpassing 2,500 Cumulative Placements of QIAsymphony
-
-
-
-
-
-
-
QIAGEN: Disclosure according to Article 5 Section (1) and (6) of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052/ Share Repurchase
-
-
-
-
-
-
-
QIAGEN Reports Results for Third Quarter and First Nine Months of 2016
-
100,001 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

